Cargando…
Hypertension Management in Patients with Chronic Kidney Disease in the Post-SPRINT Era
The management of high blood pressure (BP) is crucial for improving outcomes in patients with chronic kidney disease (CKD). The updated Kidney Disease: Improving Global Outcomes 2021 BP guideline proposes treating adults with CKD to a target systolic BP (SBP) of <120 mmHg based on the standardize...
Autor principal: | Jung, Hae Hyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Electrolyte Metabolism
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715225/ https://www.ncbi.nlm.nih.gov/pubmed/35003282 http://dx.doi.org/10.5049/EBP.2021.19.2.19 |
Ejemplares similares
-
Hypertension Management in Patients with Chronic Kidney Disease
por: Hebert, Sean A., et al.
Publicado: (2022) -
CVD risk in non-albuminuric chronic kidney disease in hypertensive, non-diabetic subjects: A post-hoc analysis from SPRINT
por: Sheng, Chang-Sheng, et al.
Publicado: (2022) -
Hypertension in pediatric patients with chronic kidney disease: management challenges
por: Gallibois, Claire M, et al.
Publicado: (2017) -
Obesity-related hypertension and chronic kidney disease: from evaluation to management
por: Jung, Mi-Hyang, et al.
Publicado: (2023) -
Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
por: Tomiyama, Hirofumi, et al.
Publicado: (2014)